US Stock MarketDetailed Quotes
KZR Kezar Life Sciences
- 6.440
- +0.060+0.94%
Close Dec 23 16:00 ET
- 6.440
- 0.0000.00%
Post 20:01 ET
46.99MMarket Cap-0.49P/E (TTM)
6.620High6.270Low60.68KVolume6.380Open6.380Pre Close391.28KTurnover1.34%Turnover RatioLossP/E (Static)7.30MShares11.35052wk High0.35P/B29.26MFloat Cap5.20252wk Low--Dividend TTM4.54MShs Float363.268Historical High--Div YieldTTM5.49%Amplitude5.200Historical Low6.448Avg Price1Lot Size
Kezar Life Sciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 13.42%-17.49M | 21.15%-17.03M | -9.60%-22.86M | -38.74%-81.65M | -19.50%-18.98M | -23.50%-20.21M | -62.54%-21.6M | -56.68%-20.86M | -38.67%-58.85M | -43.34%-15.88M |
| Net income from continuing operations | 12.08%-20.31M | 11.36%-21.55M | 2.44%-21.66M | -49.28%-101.87M | -77.44%-32.26M | -29.45%-23.1M | -50.17%-24.31M | -38.54%-22.2M | -24.91%-68.24M | -27.93%-18.18M |
| Depreciation and amortization | -6.47%260K | 4.82%261K | 0.39%260K | 4.20%1.07M | 198.94%280K | -39.30%278K | -42.23%249K | -37.89%259K | -32.25%1.02M | -173.13%-283K |
| Other non cash items | 10.34%64K | 10.17%65K | 8.47%64K | 6.25%238K | -6.06%62K | 11.54%58K | 11.32%59K | 11.32%59K | 146.15%224K | --66K |
| Change In working capital | 123.21%536K | 374.87%945K | -125.57%-3.45M | 205.54%4.71M | 14,287.93%8.35M | -5.63%-2.31M | 117.64%199K | -27.10%-1.53M | -463.70%-4.46M | -87.99%58K |
| -Change in prepaid assets | -384.04%-4.56M | 267.85%2.38M | -114.82%-237K | 161.91%3.58M | 50.74%-267K | 139.57%1.6M | 158.55%647K | 1,959.30%1.6M | -650.62%-5.79M | -177.99%-542K |
| -Change in payables and accrued expense | -48.93%1.5M | -108.82%-97K | -322.39%-3.01M | 249.89%6.35M | 379.50%959K | 35.00%2.94M | 301.46%1.1M | 262.23%1.35M | 49.06%1.81M | 233.33%200K |
| -Change in other current assets | ---- | 30.73%-1.02M | 102.13%94K | ---- | ---- | ---- | ---1.47M | ---4.41M | ---- | ---- |
| -Change in other working capital | 146.48%2.67M | -328.38%-317K | -343.28%-297K | -974.90%-5.22M | 63.25%653K | ---5.74M | ---74K | 76.33%-67K | 53.36%-486K | --400K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 13.42%-17.49M | 21.15%-17.03M | -9.60%-22.86M | -38.74%-81.65M | -19.50%-18.98M | -23.50%-20.21M | -62.54%-21.6M | -56.68%-20.86M | -38.67%-58.85M | -43.34%-15.88M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 29.54%24.06M | -7.48%12.22M | 24.51%20.41M | 183.21%76.05M | 421.88%27.88M | 175.17%18.57M | 774.37%13.2M | 127.53%16.39M | -221.31%-91.39M | 89.50%-8.66M |
| Net PPE purchase and sale | 86.26%-18K | --0 | --0 | -14.39%-1.81M | 99.71%-1K | 78.28%-131K | -656.04%-1.38M | 34.00%-297K | -399.37%-1.58M | -28.95%-343K |
| Net investment purchase and sale | 28.72%24.08M | -16.21%12.22M | 22.29%20.41M | 186.68%77.85M | 435.16%27.88M | 177.60%18.71M | 761.64%14.58M | 128.25%16.69M | -219.30%-89.81M | 89.88%-8.32M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 29.54%24.06M | -7.48%12.22M | 24.51%20.41M | 183.21%76.05M | 421.88%27.88M | 175.17%18.57M | 774.37%13.2M | 127.53%16.39M | -221.31%-91.39M | 89.50%-8.66M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -85.34%56K | 0 | -99.50%638K | -88.34%59K | -76.76%43K | -99.51%382K | -99.68%154K | 13.57%127.86M | -99.49%506K |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Net common stock issuance | --0 | -85.34%56K | --0 | --0 | 28.78%-579K | -76.76%43K | -99.51%382K | -99.68%154K | 25.33%126.54M | -100.93%-813K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | -51.63%638K | ---- | ---- | ---- | ---- | -36.71%1.32M | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -85.34%56K | --0 | -99.50%638K | -88.34%59K | -76.76%43K | -99.51%382K | -99.68%154K | 13.57%127.86M | -99.49%506K |
| Net cash flow | ||||||||||
| Beginning cash position | 0.59%28.28M | -8.57%33.03M | -12.27%35.49M | -35.66%40.46M | -58.89%26.5M | -73.33%28.11M | -7.14%36.13M | -35.66%40.46M | 196.22%62.88M | 12.89%64.45M |
| Current changes in cash | 513.48%6.57M | 40.62%-4.76M | 43.13%-2.45M | 77.83%-4.96M | 137.26%8.96M | 96.12%-1.59M | -112.04%-8.02M | 82.02%-4.32M | -153.66%-22.38M | -515.59%-24.04M |
| Effect of exchange rate changes | 169.57%16K | 160.00%3K | 41.67%-7K | 95.92%-2K | -7.32%38K | 54.90%-23K | 92.19%-5K | -148.00%-12K | 2.00%-49K | 925.00%41K |
| End cash Position | 31.55%34.86M | 0.59%28.28M | -8.57%33.03M | -12.27%35.49M | -12.27%35.49M | -58.89%26.5M | -73.33%28.11M | -7.14%36.13M | -35.66%40.46M | -35.66%40.46M |
| Free cash flow | 13.91%-17.51M | 25.87%-17.03M | -8.06%-22.86M | -38.12%-83.46M | -16.98%-18.98M | -19.91%-20.34M | -70.56%-22.98M | -53.71%-21.16M | -41.33%-60.42M | -43.00%-16.23M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data